We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

105 hedge funds and large institutions have $26.2M invested in SANGAMO THERAPEUTICS INC in 2025 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 26 increasing their positions, 32 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less call options, than puts

Call options by funds: $535K | Put options by funds: $554K

2.25% less ownership

Funds ownership: 20.75% → 18.5% (-2.2%)

6% less funds holding

Funds holding: 112 → 105 (-7)

10% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 20

19% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 32

38% less capital invested

Capital invested by funds: $42.1M → $26.2M (-$16M)

Holders
105
Holders Change
-7
Holders Change %
-6.25%
% of All Funds
1.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
26
Reduced
32
Closed
20
Calls
$535K
Puts
$554K
Net Calls
-$19K
Net Calls Change
+$169K

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
+$1.21M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$1.18M
3
LM
Luminus Management
Texas
+$482K
4
Jane Street
Jane Street
New York
+$380K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$307K

Top Sellers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
-$1.9M
2
Renaissance Technologies
Renaissance Technologies
New York
-$929K
3
Citadel Advisors
Citadel Advisors
Florida
-$641K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$276K
5
Macquarie Group
Macquarie Group
Australia
-$269K
Name Holding Trade Value Shares
Change 		Change in
Stake
Focus Partners Wealth
76
Focus Partners Wealth
Massachusetts
$4.62K -$2.81K -5,300 -33%
GRP
77
Global Retirement Partners
California
$4.41K +$5.3K +10,000 +2,041%
MFG
78
Magnus Financial Group
New York
$4.2K – – –
Osaic Holdings
79
Osaic Holdings
Arizona
$2.99K -$530 -1,000 -12%
DWS
80
Dynamic Wealth Strategies
California
$2.35K – – –
Optiver Holding
81
Optiver Holding
Netherlands
$1.34K – – –
Rockefeller Capital Management
82
Rockefeller Capital Management
New York
$1.22K – – –
Royal Bank of Canada
83
Royal Bank of Canada
Ontario, Canada
$1K -$276K -520,903 -99%
LSA
84
Leonteq Securities AG
Switzerland
$950 – – –
BLC
85
Brown, Lisle/Cummings
Rhode Island
$641 – – –
Jones Financial Companies
86
Jones Financial Companies
Missouri
$583 – – –
FFO
87
Fortitude Family Office
Arizona
$473 +$597 +1,126 New
AWM
88
Activest Wealth Management
Florida
$420 – – –
AF
89
Allworth Financial
California
$420 – – –
APW
90
Atlantic Private Wealth
North Carolina
$420 – – –
CIBC Private Wealth Group
91
CIBC Private Wealth Group
Georgia
$420 – – –
JP Morgan Chase
92
JP Morgan Chase
New York
$205 +$259 +489 New
AUB
93
Atlantic Union Bankshares
Virginia
$168 – – –
PWMG
94
Prestige Wealth Management Group
New Jersey
$126 +$159 +300 New
BNP Paribas Financial Markets
95
BNP Paribas Financial Markets
France
$112 -$95 -180 -40%
AF
96
Advisornet Financial
Minnesota
$87 – – –
SAM
97
Smartleaf Asset Management
Massachusetts
$85 +$106 +200 New
National Bank of Canada
98
National Bank of Canada
Quebec, Canada
$84 – – –
KBFS
99
Kohmann Bosshard Financial Services
Ohio
$66 +$82 +155 New
SWM
100
SHP Wealth Management
Massachusetts
$52 +$66 +125 New
1 2 3
4
5

SGMO Hedge Fund Activity: Q4 2025 in Review

105 of the 8,235 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q4 2025, worth a combined $26.2M — down 38% from $42.1M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of SGMO and 18 opened new positions — a net loss of 2 holders — while 32 trimmed existing stakes and 26 added.

The largest buyer was Two Sigma Investments, adding an estimated $1.21M. The largest seller was GSA Capital Partners, cutting an estimated $1.9M.

  • 105 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q4 2025, down from 112 in Q3 2025.
  • Funds reported $26.2M of SANGAMO THERAPEUTICS INC stock for Q4 2025, down 38% quarter-over-quarter.
  • 18 funds opened new SANGAMO THERAPEUTICS INC positions in Q4 2025 and 20 closed out, a net change of -2 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q4 2025 was Two Sigma Investments, an estimated $1.21M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q4 2025 was GSA Capital Partners, an estimated $1.9M sold.

Based on aggregated 13F filings for Q4 2025.